MDR1 Haplotypes Modify BEN Disease Risk: A Study in Bulgarian Patients with Balkan Endemic Nephropathy Compared to Healthy Controls
- 1 January 2004
- journal article
- research article
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 96 (1) , e7-e13
- https://doi.org/10.1159/000075571
Abstract
Background: Balkan endemic nephropathy (BEN) is a slow progressive nephropathy with frequent occurrence of uroepithelial tumors in the upper urinary tract. Genetic factors involved in xenobiotic detoxification mechanisms may cause genetic predisposition to BEN and influence the risk for this disease. Polymorphic MDR1 variants with decreased P-glycoprotein (P-gp) activity modulate the risk for renal neoplasm. We have therefore investigated the impact of MDR1 polymorphisms on BEN manifestation. Methods: The constitutional genotype frequencies of two SNPs (C3435T and G2677T) in the MDR1 gene in 112 healthy control subjects were investigated and compared with those of 96 patients with BEN. Identification of the SNPs was done with rapid cycle real-time PCR and melting curve analysis with allele-specific probes. Results: The frequency of mutant alleles was comparable in both groups. Significant differences were revealed when the MDR1 haplotypes were analyzed. Individuals with a predicted haplotype 12 (2677G/3435T) were less frequent in BEN cases (frequency 7.3%) than in controls (16.1%, p = 0.006). We found that carriers of the haplotype 12 had a decreased risk for BEN (OR = 0.411; 0.21–0.78). Conclusions: The data suggest that haplotype 12 is protective against BEN. There is no clear molecular explanation of the MDR1 haplotype effects on the protein activity, which can explain the modified effect of the haplotype 12 on BEN risk.Keywords
This publication has 9 references indexed in Scilit:
- Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 geneClinical Pharmacology & Therapeutics, 2002
- Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoproteinClinical Pharmacology & Therapeutics, 2002
- Identification of functionally variant MDR1 alleles among European Americans and African AmericansClinical Pharmacology & Therapeutics, 2001
- Statistics Notes: The odds ratioBMJ, 2000
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- Model-Free Analysis and Permutation Tests for Allelic AssociationsHuman Heredity, 1999
- Etiology of Balkan endemic nephropathy: A multifactorial disease?European Journal of Epidemiology, 1998
- The physiological function of drug-transporting P-glycoproteinsSeminars in Cancer Biology, 1997
- The P-glycoprotein multidrug transporterGeneral Pharmacology: The Vascular System, 1996